期刊文献+

Abnormal immunity and gene mutation in patients with severe hepatitis-B 被引量:39

Abnormal immunity and gene mutation in patients with severe hepatitis-B
下载PDF
导出
摘要 AIM: To evaluate the abnormal immunity and gene mutation at precore 1896 site in patients with severe hepatitis-B.METHODS: This study included 23 patients with severe hepatitis-B, 22 patients with acute hepatitis-B and 20 controls.Mutation at precore 1896 site of HBV gene was confirmed with restriction fragment length polymorphism (RFLP) analysis.Cytokines including TNF-α, IFN-y, IL-6, and IL-8 were measured with ELISA, and T subgroups were detected with alkaline phosphatase anti alkaline phosphatase (APAAP) technique.RESULTS: In patients with severe hepatitis-B, the infective rate of HBV mutant strain was 52.5% (12/23), and only one patient with acute hepatitis-B was infected with the mutant strain. The percentage of CD8+ T lymphocyte was obviously lower (0.16±0.02%) and the ratio of CD4+/CD8+ was obviously higher (2.35±0.89) in mutant group than in wildtype group (0.28±0.05% and 1.31±0.18%, respectively,P<0.01 or P<0.05). The levels of cytokines in patients with severe hepatitis-B were higher (TNF-α 359.0±17.2 ng/L, IFNγ 234.7±16.5 ng/L, IL-6 347.5±31.3 ng/L, IL-8 181.1±19.6ng/L) than those in acute hepatitis-B (TNF-α 220.6±8.9ng/L, IFN-γ 174.9±12.0 ng/L, IL-6 285.8±16.5 ng/L, IL-8118.4±5.1 ng/L, P<0.01 or 0.05). In patients with severe hepatitis-B, the levels of IFN-γ and IL-6 were higher in mutant group (273.4±26.6 ng/L, 387.7±32.5 ng/L) than in wild-type group (207.8±12.8 ng/L, 300.9±16.3 ng/L). The mortality of patients infected with HBV mutant strain was higher (100%)than that with wild-type (0.9%).CONCLUSION: In severe hepatitis-B, the infective rate of HBV mutant strain was high. The mutant strain induces more severe immune disorders in host, resulting in the activation of lymphocyte and release of cytokines. HBV DNA mutates easily in response to the altered immunity. Ultimately liver damage is more prominent. AIM:To evaluate the abnormal immunity and gene mutation at precore 1896 site in patients with severe hepatitis-B. METHODS:This study included 23 patients with severe hepatitis-B,22 patients with acute hepatitis-B and 20 controls. Mutation at precore 1896 site of HBV gene was confirmed with restriction fragment length polymorphism(RFLP)analysis. Cytokines including TNF-α,IFN-γ,IL-6,and IL-8 were measured with ELISA,and T subgroups were detected with alkaline phosphatase anti alkaline phosphatase(APAAP)technique. RESULTS:In patients with severe hepatitis-B,the infective rate of HBV mutant strain was 52.5 %(12/23),and only one patient with acute hepatitis-B was infected with the mutant strain.The percentage of CD8+T lymphocyte was obviously lower(0.16±0.02 %)and the ratio of CD4+/CD8+was obviously higher(2.35±0.89)in mutant group than in wild- type group(0.28±0.05 % and 1.31±0.18 %,respectively, P<0.01 or P<0.05).The levels of cytokines in patients with severe hepatitis-B were higher(TNF-α 359.0±17.2 ng/L,IFN- γ 234.7±16.5 ng/L,IL-6 347.54-31.3 ng/L,IL-8 181.1±19.6 ng/L)than those in acute hepatitis-B(TNF-α 220.6±8.9 ng/L,IFN-γ 174.9±12.0 ng/L,IL-6 285.8±16.5 ng/L,IL-8 118.4±5.1 ng/L,P<0.01 or 0.05).In patients with severe hepatitis-B,the levels of IFN-γ and IL-6 were higher in mutant group(273.4±26.6 ng/L,387.7±32.5 ng/L)than in wild-type group(207.8±12.8 ng/L,300.9±16.3 ng/L).The mortality of patients infected with HBV mutant strain was higher(100 %) than that with wild-type(0.9 %). CONCLUSION:In severe hepatitis-B,the infective rate of HBV mutant strain was high.The mutant strain induces more severe immune disorders in host,resulting in the activation of lymphocyte and release of cytokines.HBV DNA mutates easily in response to the altered immunity.Ultimately liver damage is more prominent.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第9期2009-2011,共3页 世界胃肠病学杂志(英文版)
基金 the National Natural Science Foundation of China, No.39370649
  • 相关文献

参考文献18

  • 1Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by Interferon-gamma.J Immunol 1986; 136:2445-2450. 被引量:1
  • 2Niitsuma H, Ishii M, Miura M, Toyota T. Detection of HBV precore mutation by PCR-RFLP. Nippon Rinsho 1995; 53 Suppl(Pt 2): 316-320. 被引量:1
  • 3Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatoceUular carcinoma. J Gastroenterol Hepatol 2000; 15(Suppl):E25-30. 被引量:1
  • 4Bertoletti A, Sette A, Chisari FV, Penna A, Giuberti T, Levrero M, De Carli M, Fiaccadori F, Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369:407-410. 被引量:1
  • 5Ohta A, Sekimoto M, Sato M, Koda T, Nishimura S, Iwakura Y,Sekikawa K, Nishimura T. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J Immunol 2000;165:956-961. 被引量:1
  • 6Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL,Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 2:72-74. 被引量:1
  • 7Tanaka Y, Takahashi A, Watanabe K, Takayama K, Yahata T,Habu T, Nishimura T. A pivotal role of IL-12 in Thl-dependent mouse liver iniury. Int Immunol 1996; 8:569-576. 被引量:1
  • 8Lehmann V, 16reudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and Dgalactosamine-treated mice. J Exp Med 1987: 165:657-663. 被引量:1
  • 9Zhang DF, Ren H, Jia XP, Zhou YS. Serum tumor necrosis factor(TNF) in the pathogenesis of clinical hepatic failure of HCV and/or HBV infection. Chin Med J 1993; 106:335-338. 被引量:1
  • 10Ando K, Moriyama T, GuidotTi LG, Wirth S, Schreiber RD,Schlicht HJ, Huang SN, Chisari FV. Mechanisms of class I restricted immunopathology: A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178:1541-1554. 被引量:1

同被引文献223

引证文献39

二级引证文献386

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部